ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Vincerx Inc

Vincerx Inc (VINC)

0.3394
-0.0125
( -3.55% )
Updated: 14:25:28

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.3394
Bid
0.3389
Ask
0.3394
Volume
444,502
0.3307 Day's Range 0.38
0.3161 52 Week Range 9.3722
Market Cap
Previous Close
0.3519
Open
0.35
Last Trade
1
@
0.339149
Last Trade Time
14:27:34
Financial Volume
$ 159,559
VWAP
0.358961
Average Volume (3m)
534,421
Shares Outstanding
29,671,903
Dividend Yield
-
PE Ratio
-14.04
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-40.16M

About Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.35. Over the last year, Vincerx shares have traded in a share price range of $ 0.3161 to $ 9.3722.

Vincerx currently has 29,671,903 shares outstanding. The market capitalization of Vincerx is $10.44 million. Vincerx has a price to earnings ratio (PE ratio) of -14.04.

VINC Latest News

Vincerx Pharma Reports Third Quarter 2024 Financial Results

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase 1...

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the programโ€™s potential and validating the VersAptxโ„ข...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0156-4.394366197180.3550.380.31614484420.33395428CS
4-0.0592-14.85198193680.39860.40980.31613652460.36160435CS
12-0.3006-46.968750.640.850.31615344210.50929782CS
26-0.4676-57.94299876080.8070.85860.31613478640.55960539CS
52-0.5331-61.1002865330.87259.37220.31616106621.91968382CS
156-13.2906-97.509904622213.6313.880.31612846762.05708645CS
260-19.7806-98.313121272420.1226.750.31612455613.55961248CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
$ 10.54
(318.25%)
113.63M
MULNMullen Automotive Inc
$ 3.175
(85.67%)
47.72M
PAMTPAMT Corporation
 21.85
(73.28%)
47.32k
LGMKLogicMark Inc
$ 0.20315
(52.74%)
518.36M
AGFYAgrify Corporation
$ 7.21
(49.28%)
978.35k
NGNENeurogene Inc
$ 38.31
(-46.44%)
1.22M
STIMNeuronetics Inc
$ 0.681
(-38.09%)
5.89M
RAILFreightCar America Inc
$ 9.915
(-36.89%)
2M
RMTIRockwell Medical Inc
$ 2.97
(-36.13%)
5.08M
PGYPagaya Technologies Ltd
$ 10.95
(-35.17%)
10.04M
CEROCERo Therapeutics Holdings Inc
$ 0.272899
(39.23%)
667.73M
LGMKLogicMark Inc
$ 0.20315
(52.74%)
518.36M
LIFWMSP Recovery Inc
$ 0.12
(-5.29%)
164.47M
NVDANVIDIA Corporation
$ 148.5001
(2.23%)
145.68M
ELABElevai Labs Inc
$ 0.0189
(-2.07%)
126.65M

VINC Discussion

View Posts
tw0122 tw0122 1 month ago
VINC .84 + 20% โ€ฆ05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
๐Ÿ‘๏ธ0
Laster Laster 7 months ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Canโ€™t believe they didnโ€™t try to do the financing when it was trading above $5.
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Tomorrow will be $1.50
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Blood bath. I should have waited one more day.
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Somebody knows something you donโ€™t
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
I donโ€™t find the price and volume the capital raise is. Am I missing anything here?
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Check for SEC filings
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Is the capital raise 80% discounted to yesterday price? Insane
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Check for a capital raise which means dilution
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
VINC 10Q due 4/3
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52.week hi
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Tom turtles Tom turtles 8 months ago
Very nice surprise...🆙⬆️
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
๐Ÿ‘๏ธ0
glenn1919 glenn1919 9 months ago
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
160k wall getting gobbled up
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
Another leg. Damn
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
Whoโ€™s poking it?
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
VINC under $2
๐Ÿ‘๏ธ0
make it happen make it happen 10 months ago
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
๐Ÿ‘๏ธ0
alchemytrader alchemytrader 10 months ago
moving...
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
VINC under $2
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock